Prescription 📍 ES

AIDESSIA 0,15 MG/0,03 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG

Analogs of AIDESSIA 0,15 MG/0,03 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG

Find cheaper analogs and generic equivalents for AIDESSIA 0,15 MG/0,03 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG.

Ingredients

Active Ingredient: desogestrel, ethinylestradiol

Inactive Ingredients: LACTOSA MONOHIDRATO 54.90 mg, POLISORBATO C.S mg

Product Overview

About AIDESSIA 0,15 MG/0,03 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG

AIDESSIA 0,15 MG/0,03 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG is a combined oral contraceptive tablet designed to prevent pregnancy. Each tablet contains 0,15 mg of desogestrel, a progestogen, and 0,03 mg of ethinylestradiol, an estrogen. The film-coated formulation facilitates easy swallowing and provides a smooth, uniform appearance. The medication is taken once daily, typically at the same time each day, to maintain consistent hormone levels. It is intended for use by individuals who are at least 18 years old and have no contraindications to estrogen or progestin therapy. The product is manufactured under strict quality control standards to ensure safety and efficacy. Patients should follow the prescribing information and consult a healthcare professional for personalized guidance.

Key Benefits & Uses

Effective contraception when taken as directed.
Regulation of menstrual cycles and reduction of menstrual cramps.
Improvement of acne and reduction of androgenic symptoms.

Active Ingredient & Action

Desogestrel provides progestogenic activity that inhibits ovulation, thickens cervical mucus, and alters the endometrial lining, making implantation less likely. Ethinylestradiol supplies estrogenic activity that stabilizes the endometrium, reduces breakthrough bleeding, and supports the contraceptive effect of desogestrel. Together, these hormones create a dual mechanism of action that enhances contraceptive reliability.

Important Notes

Patients should be aware of potential contraindications such as a history of thromboembolic disorders, uncontrolled hypertension, or liver disease. Smoking individuals over 35 years of age should discuss risks with a healthcare provider. The medication should not be used during pregnancy or while breastfeeding without medical advice. Regular follow-up with a healthcare professional is recommended to monitor for side effects and ensure continued suitability of the contraceptive method.